The Nifty Pharma index was trading 0.29 per cent down at 7911 around 10:11 am.
The Operations and Administrative Committee of the Company on 16th September, 2019 has allotted 1,22,883 equity shares of Rs.2/- each pursuant to exercise of the stock options by the option grantees under Employee Stock Option Scheme 2013-A of the Company. Consequently, the issued, subscribed and paid-up share capital of the Company stands increased to INR 1,61,21,54,994 comprising of 80,60,77,497 equity shares of face value Rs.2/- each.
Please find enclosed the schedule of analyst and institutional investor meetings of the Company.
India business declined 12.2% in Q1FY20 due to revenue loss of Rs2bn in the trade generic business because of realignment of distributors.
Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, attached herewith is the schedule of Analysts / Institutional Investor Meetings.
The Nifty Pharma index was trading 0.16 per cent up at 7824.45 around 10:10 am.
Please find enclosed the schedule of analyst / institutional investor meetings.
Eywa Pharma, based in Chennai and with offices in New Jersey, is the new pharma kid on the block that is entering the US market.
The Nifty Pharma index was trading 0.14 per cent down at 7659.90 around 10:10 am.
The Nifty Pharma index was trading 0.32 per cent down at 7652.75 around 10:11 am.
Sell Cipla Ltd. at a price target of Rs 455.0 and a stoploss at Rs 481 from entry point.
Please find enclosed the schedule of analyst / institutional investor meetings of the Company
Cipla Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
Please find enclosed details of the Voting Results of the 83rd Annual General Meeting of the Company held on Friday, 16th August, 2019 at 3.00 P.M. (IST) in the format as prescribed under Regulation 44(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 together with Combined Scrutinizers Report.
The summary of proceedings of Annual General Meeting (the "AGM") pursuant to Regulation 30 and Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is enclosed.
Please find enclosed copy of address made by Dr. Y.K. Hamied- Chairman at the 83rd Annnual General Meeting of the Company held on Friday, 16th August, 2019 at 3.00 p.m.at Birla Matushri Sabhagar, 19, Sir Vithaldas Thackersey Marg, New Marine Lines, Mumbai - 400 020.
There are corporate actions that often bring material changes to a company, directly affecting stakeholders.
Please find attached announcement dated 15th August, 2019.
Nifty Pharma index fell 1.4 per cent to 7,744.30 on Wednesday after hitting a 5-year low.
We are enclosing herewith copy of the transcript of the Companys Q1 FY 20 earnings conference call dated 7 August 2019. The transcript is also available on the Companys website i.e. www.cipla.com under the Investor Information section.
Domestic benchmark index NSE Nifty was trading 8.70 points down at 11,100.95.
The percentage increase in the median remuneration for the staff of the firm for FY19 was 3.96 per cent.
Prabhudas Lilladher has initiated coverage on Bajaj Finance with a target price of Rs 3,860.
We are pleased with the robust all-round performance in our key markets, said Lupin MD.
Revenue for the quarter increased mere 1.26 per cent YoY to Rs 3,894.46 crore.
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find attached letter dated 07th August, 2019.
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find attached letter dated 07th August, 2019
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find attached press release dated 07th August, 2019.
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find attached press release dated 07th August, 2019
Revenue for the quarter rose mere 1.26 per cent YoY to Rs 3,894.46 crore.
Pursuant to Regulation 30 of the SEBI Listing Regulations, 2015, it is hereby informed that Cipla Limited (the Company) has signed a definitive agreement today to acquire the minority stake of Eight Roads Investment Mauritius II Limited (earlier known as FIL Capital Investments (Mauritius) II Limited) in Cipla Health Limited, subsidiary of the Company. The details as required under the SEBI Listing Regulations are enclosed.
Please find attached letter dated 07th August, 2019
Centrum expects South Africa and RoW also to remain under pressure in terms of growth and R&D spend to remain higher around 8 per cent of sales.
Benchmark NSE Nifty50 index was down 10.45 points at 10,937.80.
HPCL, Lupin, Adani Power, Aurobindo Pharma and India Cements will announce Q1 earnings today.
Troubled DHFL said none of its creditors will have any principal haircuts as per the draft resolution plan.
DIIs were net buyers to the tune of Rs 2,289 crore, data suggests.
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mitsubishi UFJ Financial Group
On the options front, Maximum Put open interest was at 11,000 followed by 10,500 levels.
The Nifty Pharma index was trading 1.32 per cent down at 7881.75 around 10:12 am.
Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service